Medical Devices industry cross border deals total $2.6bn globally in November 2022

Total medical devices industry cross border deals worth $2.6bn were announced globally for November 2022, with WerfenLife’s $2bn acquisition deal with Immucor being the sector’s biggest investment, according to GlobalData’s deals database.

The value marked a decrease of 42.7% over the previous month of $4.54bn and a drop of 11.9% when compared with the last 12-month average of $2.95bn.

In terms of number of cross border deals, the sector saw a drop of 33.33% with 42 deals in November 2022 when compared to the last 12-month average of 63 deals.

In value terms, North America led the activity with cross border deals worth $2.52bn in November 2022.

Medical Devices industry cross border deals in November 2022: Top deals

The top five cross border deals accounted for 96.3% of the overall value during November 2022.

The combined value of the top five cross border deals stood at $2.5bn, against the overall value of $2.6bn recorded for the month.

The top five medical devices industry cross border deals of November 2022 tracked by GlobalData were:

1) WerfenLife’s $2bn acquisition deal with Immucor

2) The $449m private equity of 18% stake in Certara by Arsenal Capital Partners

3) Jolt Capital’s $20.16m private equity deal with BC Platforms

4) The $18.67m private equity of StageZero Life Sciences by GEM Global YieldSCS

5) Advanced MedTech Holdings and Lyndon Rive’s $12.4m venture financing deal with Sonomotion